Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

ClinicalTrials.gov ID: NCT01128894

Public ClinicalTrials.gov record NCT01128894. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT01128894
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
841 participants

Conditions and interventions

Interventions

  • albiglutide Biological
  • liraglutide Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Aug 31, 2011
Completion
Aug 31, 2011
Last update posted
Feb 22, 2017

2010 – 2011

United States locations

U.S. sites
129
U.S. states
34
U.S. cities
111
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35294
GSK Investigational Site Chandler Arizona 85224
GSK Investigational Site Gilbert Arizona 85295
GSK Investigational Site Phoenix Arizona 85032
GSK Investigational Site Tucson Arizona 85712
GSK Investigational Site Searcy Arkansas 72143
GSK Investigational Site Chula Vista California 91910
GSK Investigational Site Escondido California 92026
GSK Investigational Site Fresno California 93720
GSK Investigational Site Huntington Beach California 92648
GSK Investigational Site Indio California 92201
GSK Investigational Site Irvine California 92618
GSK Investigational Site Los Angeles California 90017
GSK Investigational Site Los Angeles California 90022
GSK Investigational Site Mission Viejo California 92691
GSK Investigational Site Orange California 92868
GSK Investigational Site Palm Desert California 92260
GSK Investigational Site Riverside California 92506
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Diego California 92128
GSK Investigational Site Satna Monica California 90404
GSK Investigational Site Spring Valley California 91978
GSK Investigational Site Tarzana California 91356
GSK Investigational Site Tustin California 92780
GSK Investigational Site Walnut Creek California 94598
GSK Investigational Site West Hills California 91307
GSK Investigational Site Clearwater Florida 33765
GSK Investigational Site Cocoa Florida 32927
GSK Investigational Site Miami Florida 33156
GSK Investigational Site North Miami Florida 33161
GSK Investigational Site Ocala Florida 34471
GSK Investigational Site Orlando Florida 32822
GSK Investigational Site Pembroke Pines Florida 33026
GSK Investigational Site St. Petersburg Florida 33709
GSK Investigational Site Tampa Florida 33613
GSK Investigational Site Winter Park Florida 32789
GSK Investigational Site Winter Park Florida 32792
GSK Investigational Site Atlanta Georgia 30309
GSK Investigational Site Atlanta Georgia 30312
GSK Investigational Site Atlanta Georgia 30338
GSK Investigational Site Atlanta Georgia 30342
GSK Investigational Site Blue Ridge Georgia 30513
GSK Investigational Site Roswell Georgia 30076
GSK Investigational Site Stone Mountain Georgia 30088
GSK Investigational Site Honolulu Hawaii 96814
GSK Investigational Site Idaho Falls Idaho 83404
GSK Investigational Site La Grange Illinois 60525
GSK Investigational Site Evansville Indiana 47714
GSK Investigational Site Valparaiso Indiana 46383
GSK Investigational Site Council Bluffs Iowa 51501
GSK Investigational Site Dubuque Iowa 52001
GSK Investigational Site Lexington Kentucky 40504
GSK Investigational Site Paducah Kentucky 42003
GSK Investigational Site Covington Louisiana 70433
GSK Investigational Site Shreveport Louisiana 71101
GSK Investigational Site Haverhill Massachusetts 01830
GSK Investigational Site Bloomfield Hills Michigan 48302
GSK Investigational Site Dearborn Michigan 48124
GSK Investigational Site Detroit Michigan 48235
GSK Investigational Site Kalamazoo Michigan 49009
GSK Investigational Site Kalamazoo Michigan 49048
GSK Investigational Site Saint Clair Shores Michigan 48081
GSK Investigational Site Minneapolis Minnesota 55430
GSK Investigational Site Picayune Mississippi 39466
GSK Investigational Site Kansas City Missouri 64111
GSK Investigational Site St Louis Missouri 63110
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Lincoln Nebraska 68516
GSK Investigational Site Omaha Nebraska 68131
GSK Investigational Site Las Vegas Nevada 89102
GSK Investigational Site Las Vegas Nevada 89103
GSK Investigational Site Elizabeth New Jersey 07202
GSK Investigational Site Haddon Heights New Jersey 08035
GSK Investigational Site North Massapequa New York 11758
GSK Investigational Site Staten Island New York 10301
GSK Investigational Site Burlington North Carolina 27215
GSK Investigational Site Durham North Carolina 27710
GSK Investigational Site Greensboro North Carolina 27405
GSK Investigational Site Lenoir North Carolina 28645
GSK Investigational Site Morehead City North Carolina 28557
GSK Investigational Site Shelby North Carolina 28150
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Canal Fulton Ohio 44614
GSK Investigational Site Cleveland Ohio 44122
GSK Investigational Site Columbus Ohio 43213
GSK Investigational Site Dayton Ohio 45439
GSK Investigational Site Gallipolis Ohio 45631
GSK Investigational Site Kettering Ohio 45429
GSK Investigational Site Oklahoma City Oklahoma 73103
GSK Investigational Site Portland Oregon 97239
GSK Investigational Site Downington Pennsylvania 19335
GSK Investigational Site Greer South Carolina 29651
GSK Investigational Site Murrells Inlet South Carolina 29576
GSK Investigational Site Simpsonville South Carolina 29681
GSK Investigational Site Bristol Tennessee 37620
GSK Investigational Site Clarksville Tennessee 37043
GSK Investigational Site Memphis Tennessee 38125
GSK Investigational Site Tullahoma Tennessee 37398
GSK Investigational Site Arlington Texas 76012
GSK Investigational Site Corpus Christi Texas 78404
GSK Investigational Site Dallas Texas 75230
GSK Investigational Site Dallas Texas 75246
GSK Investigational Site Dallas Texas 75251
GSK Investigational Site Fort Worth Texas 76104
GSK Investigational Site Houston Texas 77036
GSK Investigational Site Houston Texas 77074
GSK Investigational Site Houston Texas 77088
GSK Investigational Site Hurst Texas 76054
GSK Investigational Site Katy Texas 77450
GSK Investigational Site Midland Texas 79707
GSK Investigational Site North Richland Hills Texas 76180
GSK Investigational Site San Antonio Texas 78215
GSK Investigational Site San Antonio Texas 78217
GSK Investigational Site San Antonio Texas 78229
GSK Investigational Site San Antonio Texas 78237
GSK Investigational Site Schertz Texas 78154
GSK Investigational Site Sugarland Texas 77479
GSK Investigational Site Bountiful Utah 84010
GSK Investigational Site Draper Utah 84020
GSK Investigational Site West Jordan Utah 84088
GSK Investigational Site South Burlington Vermont 05403
GSK Investigational Site Burke Virginia 22015
GSK Investigational Site Manassas Virginia 20110
GSK Investigational Site Richmond Virginia 23225
GSK Investigational Site Richmond Virginia 23294
GSK Investigational Site Salem Virginia 24153
GSK Investigational Site Spokane Washington 99208
GSK Investigational Site Spokane Washington 99216
GSK Investigational Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01128894, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01128894 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →